BRCA2 and ovarian carcinoma: In support of a particularly severe influence of BRCA1 mutations, it was further shown that the mean age at diagnosis of ovarian carcinoma is significantly younger in BRCA1 (49) versus BRCA2 (58) mutation carriers but still significantly reduced compared with the general population (68) [6].